173 related articles for article (PubMed ID: 22494439)
21. A 3D linear solvation energy model to quantify the affinity of flavonoid derivatives toward P-glycoprotein.
Boccard J; Bajot F; Di Pietro A; Rudaz S; Boumendjel A; Nicolle E; Carrupt PA
Eur J Pharm Sci; 2009 Feb; 36(2-3):254-64. PubMed ID: 18955135
[TBL] [Abstract][Full Text] [Related]
22. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
[TBL] [Abstract][Full Text] [Related]
23. A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.
Cianchetta G; Singleton RW; Zhang M; Wildgoose M; Giesing D; Fravolini A; Cruciani G; Vaz RJ
J Med Chem; 2005 Apr; 48(8):2927-35. PubMed ID: 15828831
[TBL] [Abstract][Full Text] [Related]
24. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
[TBL] [Abstract][Full Text] [Related]
25. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
26. Toward the identification of a reliable 3D QSAR pharmacophore model for the CCK2 receptor antagonism.
Gupta AK; Varshney K; Saxena AK
J Chem Inf Model; 2012 May; 52(5):1376-90. PubMed ID: 22530718
[TBL] [Abstract][Full Text] [Related]
27. Combinatorial QSAR modeling of P-glycoprotein substrates.
de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
[TBL] [Abstract][Full Text] [Related]
28. Comparative QSAR analyses of competitive CYP2C9 inhibitors using three-dimensional molecular descriptors.
Lather V; Fernandes MX
Chem Biol Drug Des; 2011 Jul; 78(1):112-23. PubMed ID: 21477091
[TBL] [Abstract][Full Text] [Related]
29. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
30. A simplified model to predict P-glycoprotein interacting drugs from 3D molecular interaction field.
Zhuang XM; Xiao JH; Li JT; Zhang ZQ; Ruan JX
Int J Pharm; 2006 Feb; 309(1-2):109-14. PubMed ID: 16376035
[TBL] [Abstract][Full Text] [Related]
31. Determination and prediction of xenoestrogens by recombinant yeast-based assay and QSAR.
Li F; Chen J; Wang Z; Li J; Qiao X
Chemosphere; 2009 Mar; 74(9):1152-7. PubMed ID: 19136139
[TBL] [Abstract][Full Text] [Related]
32. Predicting myelosuppression of drugs from in silico models.
Crivori P; Pennella G; Magistrelli M; Grossi P; Giusti AM
J Chem Inf Model; 2011 Feb; 51(2):434-45. PubMed ID: 21275392
[TBL] [Abstract][Full Text] [Related]
33. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico.
Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW
J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286
[TBL] [Abstract][Full Text] [Related]
34. 3D-QSAR studies of some tetrasubstituted pyrazoles as COX-II inhibitors.
Gupta GK; Kumar A
Acta Pol Pharm; 2012; 69(4):763-72. PubMed ID: 22876620
[TBL] [Abstract][Full Text] [Related]
35. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
[TBL] [Abstract][Full Text] [Related]
36. Ligand-based pharmacophore model of N-Aryl and N-Heteroaryl piperazine alpha 1A-adrenoceptors antagonists using GALAHAD.
Zhao X; Yuan M; Huang B; Ji H; Zhu L
J Mol Graph Model; 2010 Sep; 29(2):126-36. PubMed ID: 20538497
[TBL] [Abstract][Full Text] [Related]
37. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
Miners JO; Mackenzie PI; Knights KM
Drug Metab Rev; 2010 Feb; 42(1):196-208. PubMed ID: 19795925
[TBL] [Abstract][Full Text] [Related]
38. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
39. 3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors.
Brogi S; Papazafiri P; Roussis V; Tafi A
Eur J Med Chem; 2013 Sep; 67():344-51. PubMed ID: 23880359
[TBL] [Abstract][Full Text] [Related]
40. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
Martin E; Mukherjee P; Sullivan D; Jansen J
J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
